Scientific Data From Partial-Thickness Wound Model (Porcine)

In a preclinical study of wounds inoculated with methicillin-resistant Staphylococcus aureus (MRSA), PuraPly™ Antimicrobial demonstrated a reduction in MRSA at 72 hours up to 47% greater vs other silver technologies.1


In Vitro Scientific Data

In a United States Pharmacopeia Antimicrobial Effectiveness Test, PuraPly Antimicrobial effectively reduced concentrations of Aspergillus niger, Candida albicans, Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli at days 7, 14, and 28.1


Reference: 1. Data on file. Organogenesis, Inc.